Sensus Healthcare Inc. (SRTS) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sensus Healthcare Inc. (SRTS:NASDAQ), powered by AI.

Current Price
$3.08
P/E Ratio
-6.5
Market Cap
50M
Sector
Unknown
What is the Sensus Healthcare Inc. stock price forecast?

Sensus Healthcare Inc. is currently trading at $3.08. View real-time AI analysis on Alpha Lenz.

What is Sensus Healthcare Inc. insider trading activity?

View the latest insider trading data for Sensus Healthcare Inc. on Alpha Lenz.

What is Sensus Healthcare Inc.'s P/E ratio?

Sensus Healthcare Inc.'s P/E ratio is -6.5.

Sensus Healthcare Inc.

NASDAQ · SRTS
$3.08-1.03(-25.06%)Market closedNASDAQ regular session 09:30–16:00 ET
Ask about Sensus Healthcare Inc.'s future dividend policy...
Alpha Chat Insight

Sensus Healthcare Inc. trades at a P/E of -6.5 (undervalued) with modest ROE of -14.9%.

Ask for details

Company Overview

SectorUnknown
IndustryUnknown

Company Statistics

FY 2025

Profile

$50.29MMarket Cap
$27.48MRevenue
0.00Shares Out
N/AEmployees

Margins

43.18%Gross
-35.23%EBITDA
-37.50%Operating
-35.02%Pre-Tax
-28.09%Net

Valuation

-6.51P/E
1.05P/B
1.83EV/Sales
-2.96EV/EBITDA
151.47P/FCF

Growth (CAGR)

-14.86%Rev 3Yr
23.47%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-13.40%ROA
-14.85%ROE
-17.89%ROIC

Financial Health

$22.08MCash & Cash Equivalents
$-17.14MNet Debt
10.27%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Sensus Healthcare Inc. (ticker: SRTS) is a company listed on NASDAQ in the Unknown sector (Unknown). Market cap is $50M.

The current price is $3.08 with a P/E ratio of -6.51x and P/B of 1.05x.

ROE is -14.85% and operating margin is -37.50%. Annual revenue is $27M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Sensus Healthcare Inc. (Unknown) Stock Forecast & Analysis $3.08 | Alpha Lenz